Cost-effectiveness of ceftazidime/avibactam plus metronidazole versus meropenem as first-line empiric therapy for the treatment of complicated intra-abdominal infections: A study based on the in-vitro surveillance data in China
Open Access
- 19 January 2023
- journal article
- research article
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 16 (3) , 361-367
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Epidemiology and Risk Factors for Isolation of Multi-Drug–Resistant Organisms in Patients with Complicated Intra-Abdominal InfectionsSurgical Infections, 2018
- Renal replacement therapy in acute kidney injury from a Chinese cross-sectional study: patient, clinical, socioeconomic and health service predictors of treatmentBMC Nephrology, 2017
- A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in AsiaInternational Journal of Antimicrobial Agents, 2017
- The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal InfectionSurgical Infections, 2017
- Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 ProgramClinical Infectious Diseases, 2016
- Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005–2014Clinical Microbiology and Infection, 2016
- Global validation of the WSES Sepsis Severity Score for patients with complicated intra-abdominal infections: a prospective multicentre study (WISS Study)World Journal of Emergency Surgery, 2015
- In Vitro Antibacterial Activity of the Ceftazidime-Avibactam Combination against Enterobacteriaceae, Including Strains with Well-Characterized β-LactamasesAntimicrobial Agents and Chemotherapy, 2015
- A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011Pharmaceuticals, 2013
- Distribution of Extended-Spectrum β-Lactamases, AmpC β-Lactamases, and Carbapenemases among Enterobacteriaceae Isolates Causing Intra-Abdominal Infections in the Asia-Pacific Region: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART)Antimicrobial Agents and Chemotherapy, 2013